• ASCO GI 2025 Highlights: Transforming Gastrointestinal Cancer Care

  • Jan 30 2025
  • Length: 5 mins
  • Podcast

ASCO GI 2025 Highlights: Transforming Gastrointestinal Cancer Care

  • Summary

  • ASCO GI 2025 delivered big wins in gastrointestinal oncology. We highlight key findings, including nivolumab-plus-ipilimumab in MSI-H mCRC, encorafenib-based regimens for BRAF-mutant CRC, and innovative strategies in CAR-T therapies. Catch up on the most impactful data shaping the future of cancer care. Like what you hear? Download Curie from App Store for more in-depth insights in onlcology and general medicine.

    Show More Show Less

What listeners say about ASCO GI 2025 Highlights: Transforming Gastrointestinal Cancer Care

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.